Robert A. Mack
AstraZeneca (United States)(US)
Publications by Year
Research Areas
Synthesis and Biological Evaluation, Synthesis of Organic Compounds, Organic Chemistry Synthesis Methods, Cyclopropane Reaction Mechanisms, Receptor Mechanisms and Signaling
Most-Cited Works
- → The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist(2001)158 cited
- → (−)-Spiro[1-azabicyclo[2.2.2]octane-3,5‘-oxazolidin-2‘-one], a Conformationally Restricted Analogue of Acetylcholine, Is a Highly Selective Full Agonist at the α7 Nicotinic Acetylcholine Receptor(2000)132 cited
- → Synthesis and Use of 5-Vinyl-1,2,4-oxadiazoles as Michael Acceptors. A Rapid Synthesis of the Potent Muscarinic Agonist L-670,548(1996)48 cited
- → Drug-induced modifications of the immune response. 12. 4,5-Dihydro-4-oxo-2-(substituted amino)-3-furancarboxylic acids and derivatives as novel antiallergic agents(1988)46 cited
- → A Chiral Synthesis of (−)-Spiro[1-azabicyclo[2.2.2]octane-3,5‘- oxazolidin-2‘-one]: A Conformationally Restricted Analogue of Acetylcholine That Is a Potent and Selective α7 Nicotinic Receptor Agonist(2004)28 cited
- → Drug‐induced modifications of the immune response part 94‐(Arylamino)‐2,5‐dihydro‐2‐oxo‐N‐(trans‐2‐phenylcycolopropyl)furan‐3‐carboxamides as Novel Antiallergic Compounds(1987)9 cited
- → A novel 3(2H)-furanone-2(5H)-furanone rearrangement(1987)9 cited
- → Synthesis of some novel 1,3-dihydro-2H-benzimidazol-2-ylidenes(1993)8 cited
- → Synthesis of Substituted 4,5-Dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic Acids and Ethyl Esters(1986)7 cited
- → Synthesis and biological activity of enantiomers of a conformationally restricted muscarone analog(1995)6 cited